Marie Paule Sablin

Sequential Sorafenib and Sunitinib for Renal Cell Carcinoma

Marie Paule Sablin, S. Négrier, Alain Ravaud et al. · The Journal of Urology · 2009 · 154 citations

Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie

Clémence Basse, Claire Morel, Marie Alt et al. · ESMO Open · 2018 · 55 citations · Full text

Abstract CT049: Phase Ib study evaluating a triplet combination of ipatasertib (IPAT), atezolizumab (atezo), and paclitaxel (PAC) or nab-PAC as first-line (1L) therapy for locally advanced/metastatic triple-negative breast cancer (TNBC)

Peter Schmid, Delphine Loirat, Peter Savas et al. · Cancer Research · 2019 · 47 citations

Breast Oncology, Immunology, Immunoediting +21

Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial

Marc Hilmi, Maud Kamal, Sophie Vacher et al. · European Journal of Cancer · 2023 · 37 citations · Full text

Dysbiosis, Gut Microbiology, Immunology +10

Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma

C. Daveau, Sonia Baulies, Marjorie Lalloum et al. · British Journal of Cancer · 2014 · 24 citations · Full text